Back
SELLAS Life Sciences Group Stock Predictions
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
45
SLS
SELLAS Life Sciences Group
Last Price:
1.32
Seasonality Move:
7.89%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.SELLAS Life Sciences Group Stock Forecast
-
Is SELLAS Life Sciences Group Stock Undervalued?
The current SELLAS Life Sciences Group [SLS] share price is $1.32. The Score for SLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - SLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will SELLAS Life Sciences Group Stock Go Up Next Year?
Data Unavailable
SELLAS Life Sciences Group Stock Rating
Data Unavailable
SELLAS Life Sciences Group Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sellaslifesciences.com
52-Week Data
52-Week High:
1.72
52-Week Low:
0.50
Prediction Charts
Market Cap:
84.92M
Price in USD:
1.32
Volume:
845.02K
Beta:
1.46
Technical Analysis
SMA50:
1.23
SMA100:
1.22
SMA200:
1.22
52-Wk Change:
36.08%
Stock Predictions
-
Is SELLAS Life Sciences Group stock public?
Yes, SELLAS Life Sciences Group is a publicly traded company. -
What is the SELLAS Life Sciences Group stock quote today?
The SELLAS Life Sciences Group stock price is 1.32 USD today. -
How to buy SELLAS Life Sciences Group stock online?
You can buy SELLAS Life Sciences Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-29 | 1.23 | 1.23 | 1.23 | 1.21 |
| Oct-30 | 1.23 | 1.20 | 1.23 | 1.17 |
| Oct-31 | 1.20 | 1.17 | 1.21 | 1.14 |
| Nov-1 | 1.15 | 1.19 | 1.21 | 1.14 |
| Nov-4 | 1.17 | 1.17 | 1.18 | 1.14 |
| Nov-5 | 1.17 | 1.18 | 1.20 | 1.14 |
| Nov-6 | 1.19 | 1.16 | 1.20 | 1.15 |
| Nov-7 | 1.18 | 1.16 | 1.21 | 1.15 |
| Nov-8 | 1.16 | 1.23 | 1.24 | 1.16 |
| Nov-11 | 1.22 | 1.26 | 1.31 | 1.20 |
| Nov-12 | 1.26 | 1.35 | 1.38 | 1.24 |
| Nov-13 | 1.38 | 1.28 | 1.39 | 1.26 |
| Nov-14 | 1.28 | 1.27 | 1.37 | 1.22 |
| Nov-15 | 1.28 | 1.32 | 1.35 | 1.25 |
SELLAS Life Sciences Group Earnings
Data Unavailable
SELLAS Life Sciences Group Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.04 per share.
* SELLAS Life Sciences Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.